14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hemodialysis Does Not Induce Detectable Activation of the Contact System of Coagulation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Systemic anticoagulation is administered during hemodialysis to prevent clotting of the extracorporeal circuit. The role of contact system activation in thrombin generation during hemodialysis using current era dialyzer membranes is unknown.

          Methods

          We performed a single-center randomized crossover study. Ten patients treated with hemodialysis underwent 3 standardized hemodialysis sessions. For every patient, each session was performed with a different type of dialyzer membrane (polyphenylene [PP], polymethylmetacrylate [PMMA], polyethylenimine-coated polyacrylonitrile [AN69ST]). Blood samples were collected before and 5, 15, 30, 90, and 240 minutes after blood pump start to evaluate coagulation activation (thrombin–antithrombin complex [TAT], prothrombin fragment 1+2 [PF1+2], activated factor XII [FXIIa], kallikrein, activated factor XI [FXIa]). Plasma of healthy volunteers (n = 20) was used as a reference.

          Results

          Baseline TAT and PF1+2 levels were higher in hemodialysis patients compared to healthy controls (median [interquartile range] for TAT: 3.3 [2.9–4.2] vs. 2.4 [2.3–2.5] μg/l [ P = 0.0002] and for PF1+2: 647 [478–737] vs. 138 [125–254] pmol/l [ P < 0.0002]). Despite the use of systemic anticoagulation, TAT further increased during treatment, with the increase starting after 30 minutes (median TAT at t240: 9.0 μg/l (PP), 5.5 μg/l (PMMA), and 7.2 μg/l (AN69ST), all P < 0.05 vs. baseline). Contact system markers FXIIa and kallikrein did not differ significantly between dialysis patients and healthy controls, whereas baseline FXIa levels were significantly lower in dialysis patients compared to healthy controls ( P = 0.001). Levels of all contact system markers remained unchanged during hemodialysis with all types of dialyzer membranes.

          Conclusion

          Routine hemodialysis using systemic heparin anticoagulation induces coagulation activation without measurable contact system activation.

          Graphical abstract

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Contact system revisited: an interface between inflammation, coagulation, and innate immunity.

          The contact system is a plasma protease cascade initiated by factor XII (FXII) that activates the proinflammatory kallikrein-kinin system and the procoagulant intrinsic coagulation pathway. Anionic surfaces induce FXII zymogen activation to form proteolytically active FXIIa. Bacterial surfaces also have the ability to activate contact system proteins, indicating an important role for host defense using the cooperation of the inflammatory and coagulation pathways. Recent research has shown that inorganic polyphosphate found in platelets activates FXII in vivo and can induce coagulation in pathological thrombus formation. Experimental studies have shown that interference with FXII provides thromboprotection without a therapy-associated increase in bleeding, renewing interest in the FXIIa-driven intrinsic pathway of coagulation as a therapeutic target. This review summarizes how the contact system acts as the cross-road of inflammation, coagulation, and innate immunity.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cardiovascular disease in haemodialysis: role of the intravascular innate immune system

              Haemodialysis is associated with a high risk of cardiovascular events. Here, the authors discuss the mechanisms by which biomaterial-induced activation of the complement, contact and coagulation systems might contribute to the generation of arteriosclerosis and cardiovascular disease in patients on haemodialysis.
                Bookmark

                Author and article information

                Contributors
                Journal
                Kidney Int Rep
                Kidney Int Rep
                Kidney International Reports
                Elsevier
                2468-0249
                13 March 2020
                June 2020
                13 March 2020
                : 5
                : 6
                : 831-838
                Affiliations
                [1 ]Division of Nephrology and Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                [2 ]Department of Hematology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                [3 ]Interfaculty Center for Data Processing & Statistics, Vrije Universiteit Brussel (VUB), Brussels, Belgium
                Author notes
                [] Correspondence: Karlien François, Division of Nephrology and Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels 1090, Belgium. karlien.francois@ 123456uzbrussel.be
                Article
                S2468-0249(20)31117-7
                10.1016/j.ekir.2020.03.010
                7270976
                82e7415e-0b94-45aa-a090-fa8f16db418e
                © 2020 International Society of Nephrology. Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 21 October 2019
                : 18 February 2020
                : 3 March 2020
                Categories
                Clinical Research

                blood coagulation,clotting,factor xia,factor xiia,hemodialysis,plasma kallikrein

                Comments

                Comment on this article